We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hospira’s Remicade Biosimilar Shows Comparable Patient Response: Study
Hospira’s Remicade Biosimilar Shows Comparable Patient Response: Study
Postmarket monitoring results on Hospira’s biosimilar of Janssen’s Remicade continue to show comparable patient response to the reference, the generics maker says.